APOE and glioma: The activated LXRs enhances cholesterol efflux and decreases cholesterol influx by upregulating ApoE, resulting in the cholesterol de novo synthesis and the alteration of cholesterol homeostasis in IDH-1 mutant glioma cells, which further contributes to glioma progression (Yang et al., 2020a).